Jabir, R. S. (2015). Pharmacogenetics of CYP450A, ABCB1, ABCC2, SLCO1B3 gene polymorphisms and plasma alpha-1-acid glycoprotein level on nonhaematological adverse events of docetaxel in Malaysian breast cancer patients.
Chicago Style (17th ed.) CitationJabir, Rafid Salim. Pharmacogenetics of CYP450A, ABCB1, ABCC2, SLCO1B3 Gene Polymorphisms and Plasma Alpha-1-acid Glycoprotein Level on Nonhaematological Adverse Events of Docetaxel in Malaysian Breast Cancer Patients. 2015.
MLA (9th ed.) CitationJabir, Rafid Salim. Pharmacogenetics of CYP450A, ABCB1, ABCC2, SLCO1B3 Gene Polymorphisms and Plasma Alpha-1-acid Glycoprotein Level on Nonhaematological Adverse Events of Docetaxel in Malaysian Breast Cancer Patients. 2015.
Warning: These citations may not always be 100% accurate.